A Trademark

Trademark Overview


On Friday, June 14, 2019, a trademark application was filed for A with the United States Patent and Trademark Office. The USPTO has given the A trademark a serial number of 88474039. The federal status of this trademark filing is REGISTERED as of Tuesday, June 16, 2020. This trademark is owned by Aviceda Therapeutics Inc.. The A trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the fields of ocular degenerative, inflammatory, allergic, diabetic retinopathy, macular degeneration, and fibrotic diseases; clinical trials in the fields of ocular degenerative, inflammatory, allergic, diabetic retinopathy, macular degeneration, and fibrotic diseases; providing a website with information on medical research in the fields of ocular degenerative, inflammatory, and fibrotic diseases via the Internet
a

General Information


Serial Number88474039
Word MarkA
Filing DateFriday, June 14, 2019
Status700 - REGISTERED
Status DateTuesday, June 16, 2020
Registration Number6081671
Registration DateTuesday, June 16, 2020
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 15, 2019

Trademark Statements


Description of MarkThe mark consists of the letter "A" with an eye and eyebrow crossing through the middle of the "A".
Pseudo MarkAVICEDA
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesResearch and development in the fields of ocular degenerative, inflammatory, allergic, diabetic retinopathy, macular degeneration, and fibrotic diseases; clinical trials in the fields of ocular degenerative, inflammatory, allergic, diabetic retinopathy, macular degeneration, and fibrotic diseases; providing a website with information on medical research in the fields of ocular degenerative, inflammatory, and fibrotic diseases via the Internet

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 27, 2019
Primary Code042
First Use Anywhere DateFriday, June 14, 2019
First Use In Commerce DateFriday, June 14, 2019

Trademark Owner History


Party NameAviceda Therapeutics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Party NameAviceda Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Party NameAviceda Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Tuesday, June 18, 2019NEW APPLICATION ENTERED
Thursday, June 27, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 28, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, September 6, 2019ASSIGNED TO EXAMINER
Saturday, September 7, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 25, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 15, 2019PUBLISHED FOR OPPOSITION
Tuesday, October 15, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 10, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 14, 2020TEAS STATEMENT OF USE RECEIVED
Thursday, April 30, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 30, 2020STATEMENT OF USE PROCESSING COMPLETE
Thursday, May 14, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, May 15, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 16, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, July 20, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 14, 2020USE AMENDMENT FILED
Tuesday, July 20, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 20, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 16, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED